FindTrial
Sign In

Clinical Trial of Human TGFBI Gene Mutation Detection Kit (Fluorescent PCR Method)

Clinical Trial of Human TGFBI Gene Mutation Detection Kit (Fluorescent PCR Method)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300078411
Enrollment
Unknown
Registered
2023-12-07
Start date
2023-12-08
Completion date
Unknown
Last updated
2023-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

corneal dystrophy,CD

Interventions

Gold Standard:Comparison methods :Sanger sequencing method
Index test:Product name:Human TGFBI Gene Mutation Detection Kit (Fluorescent PCR Method)

Sponsors

BEIJING TONGREN HOSPITAL,CMU
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 100 Years

Inclusion criteria

Inclusion criteria: 1.1 People with suspected or confirmed cases of various types of corneal dystrophy or people with a family history of corneal dystrophy; 1.2 There is no age limit, no gender limit; 1.3 Voluntary participation in this Clinical Trial.

Exclusion criteria

Exclusion criteria: 2.1 People who have corneal problems due to trauma; 2.2 In the opinion of the investigator, it is not suitable for participants, such as participation in the trial may put the subject at significant risk and may confound the results of the study.

Design outcomes

Primary

MeasureTime frame
Human TGFBI Gene;sensitivity;specificity;total consistent rate;—

Secondary

MeasureTime frame
Slit-lamp examination;—

Countries

China

Contacts

Public ContactDeng Yingping, Zhou Yi

West China Hospital of Sichuan University

dyp558@163.com+86 189 8060 1736

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026